当前位置:首页 - 行情中心 - 益盛药业(002566) - 财务分析 - 现金流量表

益盛药业

(002566)

  

流通市值:18.47亿  总市值:26.38亿
流通股本:2.32亿   总股本:3.31亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金201,484,029.37717,941,855.94519,011,690.96351,421,944.18
  收到的税费返还232,004.03703,253.65571,542.12412,733.35
  收到其他与经营活动有关的现金10,379,069.7419,797,954.9616,139,916.6611,179,229.49
  经营活动现金流入小计212,095,103.14738,443,064.55535,723,149.74363,013,907.02
  购买商品、接受劳务支付的现金22,237,359.4486,056,636.3465,603,422.444,501,620.2
  支付给职工以及为职工支付的现金33,852,466.16127,575,337.3687,882,445.8959,205,768.9
  支付的各项税费23,768,308.1790,474,137.6168,038,842.6246,110,323.96
  支付其他与经营活动有关的现金100,634,563.49335,597,339.39272,649,594.8179,847,250.3
  经营活动现金流出小计180,492,697.26639,703,450.7494,174,305.71329,664,963.36
  经营活动产生的现金流量净额31,602,405.8898,739,613.8541,548,844.0333,348,943.66
二、投资活动产生的现金流量:
  收回投资收到的现金160,000,000450,000,000450,000,000450,000,000
  取得投资收益收到的现金2,999,228.6913,015,093.7711,287,510.4511,287,510.45
  处置固定资产、无形资产和其他长期资产收回的现金净额-275,210.14594,278.52594,278.52
  投资活动现金流入小计162,999,228.69463,290,303.91461,881,788.97461,881,788.97
  购建固定资产、无形资产和其他长期资产支付的现金1,195,665.2213,640,591.6413,035,878.58,860,853.37
  投资支付的现金50,000,000501,762,177.52450,036,700450,000,000
  支付其他与投资活动有关的现金-1,303,300--
  投资活动现金流出小计51,195,665.22516,706,069.16463,072,578.5458,860,853.37
  投资活动产生的现金流量净额111,803,563.47-53,415,765.25-1,190,789.533,020,935.6
三、筹资活动产生的现金流量:
  取得借款收到的现金210,000,000333,000,000348,000,000348,000,000
  收到其他与筹资活动有关的现金7,400,00020,000,000--
  筹资活动现金流入小计217,400,000353,000,000348,000,000348,000,000
  偿还债务支付的现金170,000,000355,000,000310,000,000310,000,000
  分配股利、利润或偿付利息支付的现金2,842,505.8445,607,753.1142,304,293.539,052,916.55
  支付其他与筹资活动有关的现金17,151,772.65,641,791.155,553,296.054,816,000.1
  筹资活动现金流出小计189,994,278.44406,249,544.26357,857,589.55353,868,916.65
  筹资活动产生的现金流量净额27,405,721.56-53,249,544.26-9,857,589.55-5,868,916.65
四、汇率变动对现金及现金等价物的影响-0.04164.38-2.34
五、现金及现金等价物净增加额170,811,690.87-7,925,531.2830,500,464.9530,500,964.95
  加:期初现金及现金等价物余额63,554,309.9171,479,841.1971,479,841.1971,479,841.19
  期末现金及现金等价物余额234,366,000.7863,554,309.91101,980,306.14101,980,806.14
补充资料:
  净利润-28,930,178.16-19,826,023.74
  资产减值准备-5,174,518.61-1,981,582.18
  固定资产和投资性房地产折旧-35,820,571.82-19,083,407.53
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-35,820,571.82-19,083,407.53
  无形资产摊销-2,683,316.86-1,341,971.16
  长期待摊费用摊销-684,267.45-333,267.42
  处置固定资产、无形资产和其他长期资产的损失--400,967.64--282,362.32
  固定资产报废损失-303,922.18-231,142.14
  公允价值变动损失-3,824,213.82-5,163,499.61
  财务费用-12,621,806.38-6,526,525.43
  投资损失--13,350,997.91--11,471,517.38
  递延所得税--3,130,766.38--1,276,523.4
  其中:递延所得税资产减少--2,700,146.98--597,337.31
    递延所得税负债增加--430,619.4--679,186.09
  存货的减少-43,027,579.96-13,355,480.87
  经营性应收项目的减少--29,646,137.38--33,163,097.27
  经营性应付项目的增加-8,005,071.06-9,455,763.49
  现金的期末余额-63,554,309.91-101,980,806.14
  减:现金的期初余额-71,479,841.19-71,479,841.19
  现金及现金等价物的净增加额--7,925,531.28-30,500,964.95
公告日期2026-04-252026-04-172025-10-272025-08-23
审计意见(境内)标准无保留意见
TOP↑